The front page of AI-driven biology
Thursday, October 15, 2026Thu, Oct 15
Updated 6:32 PM PT
The National Institutes of Health released a pilot tool called Linked Discoveries to help scientists track citations, topic connections, and reproducibility across PubMed papers.
Beacon reported that its RPGR gene therapy, laru-zova, met its primary endpoint in an 85-patient pivotal study for X-linked retinitis pigmentosa, an inherited condition that causes progressive blindness.
Boehringer Ingelheim will use Envisagenics' SpliceCore machine-learning platform to identify and validate tumor-specific targets originating from aberrant RNA splicing, with total potential deal payments reaching $1 billion.
Regulatory T cell specialist TRex Bio and blood pressure drugmaker Retension Pharmaceuticals filed initial public offering paperwork with the Securities and Exchange Commission, joined by existing backer Eli Lilly indicating interest in buying more shares in TRex.
The FDA has approved IntraBio's Aqneursa, an orally administered modified amino acid known as levacetylleucine, to treat neurological symptoms in patients with ataxia-telangiectasia.
Australian radiopharmaceutical company Telix will acquire Germany-based ITM for $1.65 billion upfront, with up to $700 million in additional regulatory and commercial milestone payments.
Cue Biopharma reported that its injected allergy drug CUE-221 met its primary endpoint in a 145-patient Phase 2 trial for chronic spontaneous urticaria, a severe hives condition.
RetroChimera combines models with complementary inductive biases through a learned ensembling method to predict chemical synthesis pathways, outperforming leading retrosynthesis baselines across varying training data sizes.
Researchers built a graph neural network that embeds evolutionary trees directly into its architecture, improving predictions of animal host origins for paramyxoviruses.
Researchers introduced PREpiBind, a dual-stream neural network that tests ten different protein representations for predicting how peptides bind class II major histocompatibility complex (MHC-II) proteins, which present antigens to immune cells.
Researchers developed ARCHER-LD, a multi-GPU tool coded in Python using CuPy that computes genetic correlation matrices, known as linkage disequilibrium, across millions of DNA variants.